Princeton Global Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$312K Buy
4,520
+270
+6% +$18.6K 0.06% 161
2025
Q1
$295K Buy
4,250
+1,469
+53% +$102K 0.06% 158
2024
Q4
$239K Buy
2,781
+1,000
+56% +$86K 0.04% 180
2024
Q3
$213K Sell
1,781
-148
-8% -$17.7K 0.04% 182
2024
Q2
$275K Buy
1,929
+882
+84% +$126K 0.06% 147
2024
Q1
$134K Buy
1,047
+307
+41% +$39.4K 0.03% 182
2023
Q4
$76.6K Hold
740
0.02% 221
2023
Q3
$67.3K Hold
740
0.02% 223
2023
Q2
$59.9K Hold
740
0.02% 239
2023
Q1
$58.9K Hold
740
0.02% 244
2022
Q4
$50K Hold
740
0.02% 241
2022
Q3
$37K Hold
740
0.01% 266
2022
Q2
$41K Hold
740
0.01% 269
2022
Q1
$41K Hold
740
0.01% 283
2021
Q4
$41K Hold
740
0.01% 273
2021
Q3
$36K Hold
740
0.01% 284
2021
Q2
$31K Hold
740
0.01% 299
2021
Q1
$25K Sell
740
-2,400
-76% -$81.1K 0.01% 305
2020
Q4
$110K Hold
3,140
0.04% 190
2020
Q3
$109K Hold
3,140
0.04% 176
2020
Q2
$102K Buy
3,140
+740
+31% +$24K 0.03% 208
2020
Q1
$72K Hold
2,400
0.03% 207
2019
Q4
$69 Hold
2,400
0.03% 214
2019
Q3
$61K Hold
2,400
0.03% 190
2019
Q2
$61K Hold
2,400
0.04% 201
2019
Q1
$62K Hold
2,400
0.04% 180
2018
Q4
$55K Buy
+2,400
New +$55K 0.05% 154